177Lu-PSMA-R2

Lutetium-177 PSMA-R2 · Advanced Accelerator Applications

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 177Lu-PSMA-R2, covering 2025-05-13 to 2025-05-13. Get the full timeline:

Most recent: Clinical Trial Update: 177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer [Phase 1]

See pricing